⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRB News
Spruce Biosciences, Inc. Common Stock
Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations
businesswire.com
SPRB
Form 8-K
sec.gov
SPRB
Form 8-K
sec.gov
SPRB
Form 8-K
sec.gov
SPRB
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
businesswire.com
SPRB
Spruce Biosciences to Present at Upcoming Investor Conferences in March
businesswire.com
SPRB
Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
businesswire.com
SPRB
Spruce Biosciences to Participate in the Oppenheimer 36 th Annual Healthcare Life Sciences Conference
businesswire.com
SPRB
Spruce Biosciences to Participate in the Oppenheimer 36 th Annual Healthcare Life Sciences Conference
businesswire.com
SPRB
Long-Term Data Presented at the 22 nd Annual WORLDSymposium™ Highlights Tralesinidase Alfa Enzyme Replacement Therapy’s Potential as the First Disease-Modifying Treatment Option for Sanfilippo Syndrome Type B (MPS IIIB)
businesswire.com
SPRB